6 ms·
D1 receptors may be a more important target than D2 for antipsychotic drugs
- andsoitis 3y agohttps://archive.is/jyduf https://archive.is/jyduf
- imchillyb 3y agoAlternate title: D1 receptors make for better targets than D2 receptors.
- fylham 3y agoI would even add “Based on studies in mice, D1 receptors might make for better targets than D2 receptors”
- imchillyb 3y agoThat would be a welcome clarification.
- caycep 3y agomy guess is this is like saying the odd registers on a chip are involved, vs the even registers. But it is actually hard to infer what the actually program running does, not to mention what bug in the program is causing the problem. But some substance deactivates the odd registers somehow without taking down the whole chip.
- heavyset_go 3y agoMice given amphetamines
- NoZebra120vClip 3y agoA prescriber let slip to me at least once. Regarding SSRIs too. "Well, we don't really know how they work, but..." That's not science, that's a cargo cult.
- faeriechangling 3y agoNot really, you don't have to understand something to take advantage of it. My grandmother doesn't really understand how computers work but she still loves using her computer. Psychiatrists love SSRIs because they are efficacious (for a much smaller minority of those prescribed them than people realise), even when they're not more effective than placebo - placebos are actually pretty effective at treating issues. They're relatively cheap, easy to get patients who might be going through various issues to comply with the treatment, SSRI's being efficacious for the first few months after starting treatment is not that controversial, and that can allow you to monkey branch to more sustainable forms of treatment. The fact psychiatrists are prescribing drugs for a mental illness when they aren't aware of its mechanism of action is far from the worst sin of psychiatry. First off, the very notion that psychiatrists/doctors should gatekeep prescriptions in the first place being helpful isn't an evidence based practice, and how we define and diagnose mental illness in the first place is a Pandora's box of assumptions.
- fylham 3y agoWell given how complex the brain is, and how young neuroscience is, it’s no surprise that we haven’t unlocked deep knowledge about why psychopharmacological agents work. But granted the above, it isn’t prudent to wait decades for the brain to be understood before we try to help people struggling with mental health. If we can demonstrate that something is reasonably safe and makes a decent difference in helping someone’s life, shouldn’t we offer it to them (even if we don’t know on a deep level how it works)?
- NoZebra120vClip 3y ago> If Yes, if. We can, and we have, but instead the field has been usurped by junk science, and those who would dump industrial waste on us and into the water supply.
- whats_a_quasar 3y agoHuh? What exactly are you claiming?
- archieherman 3y ago[dead]
- soudiere 3y ago"interaction of dopamine and acetylcholine systems in the rat ... to direct D-amphetamine administration ... The increases observed during amphetamine ... were both blocked by co-administration with the D1 antagonist ... but not with the D2 antagonist" https://pubmed.ncbi.nlm.nih.gov/9881866/ https://pubmed.ncbi.nlm.nih.gov/9881866/ New paper models psychosis by administering amphetamines to mice, and concludes the D1 receptor is more important in psychosis. Relative binding affinities for D1 and D2 of many antipsychotics shown here https://www.cambridge.org/core/journals/cns-spectrums/article/drugs-for-psychosis-and-mood-unique-actions-at-d3-d2-and-d1-dopamine-receptor-subtypes/1141A0DF13B78B1157ED2020276CA171 https://www.cambridge.org/core/journals/cns-spectrums/articl... There are already 3 antipsychotics on the market that have a D1 binding affinity that is an order of magnitude higher than D2.
- trehalose 3y agoAmphetamine overusage isn't necessarily a great model of psychosis, or at least not of schizophrenia. It induces the "positive symptoms" of schizophrenia, but not so much the "negative symptoms" that can be more disabling and not as responsive to (or even worsened by) antipsychotics.
- topato 3y agoNot to mention many atypicals can worsen amphetamine psychosis. This whole study seems like an utter waste.
- tbalsam 3y agoThis article make very little sense to me, though I could be completely missing something here. Most psychotomimetic models of the dopamine receptor use D2 agonists (though this is not the only receptor that can be interacted with to generate these effects, IIRC. The glutamate system is implicated as well for direct effects, I believe. You'll have to check me on that one though).. Gen 3 antipsychotics for example partially agonise the receptor to block some psychotic effects without the full blockage that pure antagonists offer. They use a non-psychotomimetic drug, amphetamines, which is warning sign number one. Warning sign number 2: IIRC, the D2 receptor is the _autoregulatory receptor_ for dopamine release, IIRC. That is, it's part of the brake system for that receptor. Of course blocking it will cause problems! What is this article even reporting on? How did this get through? Am I missing something painfully obvious here? I am not a doctor or a medical researcher (yet?), just very interested in psychopharmacotherapeutics. :'////
- moraglester 3y ago[dead]